JCI I-AMI-1 ASA on Arrival Specifications SAMPLE 2012

Embed Size (px)

Citation preview

  • 7/25/2019 JCI I-AMI-1 ASA on Arrival Specifications SAMPLE 2012

    1/14

    Version 2.0

    UseCtrl + Homekeys to go to the title page

    Specification Manual for the Joint Commission International Library of MeasuresVersion 2.0, effective for January 2013 discharges (1st Quarter 2013)2011 Joint Commission International

    Joint Commission

    InternationalAcute Myocardial Infarction

    (I-AMI) Measure Set

  • 7/25/2019 JCI I-AMI-1 ASA on Arrival Specifications SAMPLE 2012

    2/14

    Version 2.0

    UseCtrl + Homekeys to go to the title page

    Specification Manual for the Joint Commission International Library of MeasuresVersion 2.0, effective for January 2013 discharges (1st Quarter 2013)2011 Joint Commission International

    Contents

    I-AMI Hospital Inpatient Quality Measures .................................................................................... 2I-AMI Data Element/Variable List ..................................................................................................4I-AMI Initial Eligible Patient Population Criteria.............................................................................. 5I-AMI Initial Eligible Patient Population Word Algorithm .................................................................6Measure Inform ation Form s (includin g Information Form s, Overviews, Detai ls, References,

    Flowch arts, Word Alg ori thm s, and Appendices)

    I-AMI-1: Aspirin on Arrival .................................................................................................. 7I-AMI-2: Aspirin Prescribed at Discharge .................................................................................... 15I-AMI-3: ACEI of ARB for LVSD ......................................................................................... 22I-AMI-4: Adult Smoking Counseling ................................................................................... 33

    I-AMI-5: Beta Blocker Prescribed at Discharge .................................................................. 41I-AMI-9: Inpatient AMI Mortality ......................................................................................... 48

    Appendix A: International Classification of Diseases (ICD) Code Tables ........................... 55

  • 7/25/2019 JCI I-AMI-1 ASA on Arrival Specifications SAMPLE 2012

    3/14

    Version 2.0

    UseCtrl + Homekeys to go to the title page

    Specification Manual for the Joint Commission International Library of MeasuresVersion 2.0, effective for January 2013 discharges (1st Quarter 2013)2011 Joint Commission International

    Joint Commission International Acute Myocardial Infarction (I-AMI)Hospital Inpatient Quality Measures

    I-Acute Myocardial Infarction (I-AMI)Measure Code Measure Short Name Measure Description

    I-AMI-1 Aspirin at Arrival Aspirin received within 24 hours of arrival the hospital for patients having an AcuteMyocardial Infarction (AMI).

    I-AMI-2 Aspirin Prescribed at Discharge Aspirin prescribed at discharge for patientwho had an Acute Myocardial Infarction(AMI).

    I-AMI-3 ACEI or ARB for LVSD ACEI (Angiotensin Converting EnzymeInhibitor) or ARB (Angiotensin Receptor

    Blocker) for patients who have LVSD (LeftVentricular Systolic Dysfunction) afterhaving an Acute Myocardial Infarction.

    I-AMI-4 Adult Smoking CessationAdvice/Counseling

    Adult Smoking Cessation (cigarette)advice/counseling given to patients whohad an Acute Myocardial Infarction.

    I-AMI-5 Beta Blocker Prescribed atDischarge

    Beta blocker prescribed at discharge forpatients who had an Acute MyocardialInfarction (AMI).

    I-AMI-9 Inpatient Mortality Acute Myocardial Infarction (AMI) patientswho expire during the hospital stay

  • 7/25/2019 JCI I-AMI-1 ASA on Arrival Specifications SAMPLE 2012

    4/14

    Version 2.0

    UseCtrl + Homekeys to go to the title page

    Specification Manual for the Joint Commission International Library of MeasuresVersion 2.0, effective for January 2013 discharges (1st Quarter 2013)2011 Joint Commission International

    I-AMI Data Element/Variable List

    General Data Element Name Collected For:

    Admission Date All measures

    Birthdate All measures

    Discharge Date All measures

    Hospital Patient Identifier All measures

    ICD Other Diagnosis Code All measures

    ICD Principal Diagnosis Code All measures

    Sex All measures

    Data Element Name Collected For:

    ACEI Prescribed at Discharge I-AMI-3Adult Smoking Counseling I-AMI-4

    Adult Smoking History I-AMI-4

    ARB Prescribed at Discharge I-AMI-3

    Arrival Date I-AMI-1

    Aspirin Prescribed at Discharge I-AMI-2

    Aspirin Received Within 24 Hours Before or AfterHospital Arrival

    I-AMI-1

    Beta Blocker Prescribed at Discharge I-AMI-5

    Discharge Disposition I-AMI-1, I-AMI-2, I-AMI-3, I-AMI-4, I-AMI-I-AMI-9

    LVSD I-AMI-3Reason for No ACEI and No ARB at Discharge I-AMI-3

    Reason for No Aspirin at Discharge I-AMI-2

    Reason for No Aspirin on Arrival I-AMI-1

    Reason for No Beta Blocker at Discharge I-AMI-5

    Transfer From Another Hospital I-AMI-9

  • 7/25/2019 JCI I-AMI-1 ASA on Arrival Specifications SAMPLE 2012

    5/14

    Version 2.0

    UseCtrl + Homekeys to go to the title page

    Specification Manual for the Joint Commission International Library of MeasuresVersion 2.0, effective for January 2013 discharges (1st Quarter 2013)2011 Joint Commission International

    I-AMI Initial Eligible Patient Population Criteria

    The population of the I-AMI measure set is identified using 4 data elements/variables:

    ICD Principal Diagnosis Code

    Admission Date

    Birthdate

    Discharge Date

    Patients admitted to the hospital for inpatient acute care with an ICD Principal Diagnosis

    Code or principal diagnosis of Acute Myocardial Infarction (AMI) as defined inAppendix

    A, Table 1.1ANDa Patient Age (Admission Date minus Birthdate) greater than or equal

    to 18 years of age are included in the I-AMI Initial Patient Population and are

    eligible to be sampled.

    For more information on sampling, go to Appendix I: Measure Sampling.

  • 7/25/2019 JCI I-AMI-1 ASA on Arrival Specifications SAMPLE 2012

    6/14

    Version 2.0

    UseCtrl + Homekeys to go to the title page

    Specification Manual for the Joint Commission International Library of MeasuresVersion 2.0, effective for January 2013 discharges (1st Quarter 2013)2011 Joint Commission International

    I-AMI Initial Eligible Patient Population Word AlgorithmVariable Key: Patient Age, and Initial Population Reject Case

    1. Start AMI Initial Patient Population logic sub-routine. Process all quarterly dischargeinpatient cases (cases with discharge dates in the specific data collection time period)that have successfully reached the point in the Data Processing Flow: Do not processcases that have been rejected before this point in the Data Processing Flow.

    2. Check ICD Principal Diagno sis Cod ea. If the ICD Principal Diagnosis Code is not on Table 1.1, the patient is not in the AMI

    Initial Patient Population and is not eligible to be sampled for the AMI measure set.

    Set the Initial Patient Population to equal reject case. Return to Data ProcessingFlow.

    b. If the ICD Principal Diagnosis Code is on Table 1.1, continue processing andproceed to Patient Age calculation.

    3. Calculate Patient Age. Patient Age, in years, is equal to the Admission Date minus theBirthdate. Use the month and day portion of Admission Date and Birthdate to yield themost accurate age.

    4. Check Patient Agea. If the Patient Age is less than 18 years, the patient is not in the I-AMI Initial Patient

    Population and is not eligible to be sampled for the I-AMI measure set. Set the InitialPatient Population to equal reject case. Return to Data Processing Flow.b. If the Patient Age is greater than or equal to 18 years, continue processing and

    proceed to each measures Clinical Data Processing Flow.

  • 7/25/2019 JCI I-AMI-1 ASA on Arrival Specifications SAMPLE 2012

    7/14

    Version 2.0

    UseCtrl + Homekeys to go to the title page

    Specification Manual for the Joint Commission International Library of MeasuresVersion 2.0, effective for January 2013 discharges (1st Quarter 2013)2011 Joint Commission International

    I-AMI-1: Aspirin on Arrival

    Measure Overview

    I-AMI-1 Aspirin received within 24 hours of arrival to the hospital for patientshaving an Acute Myocardial Infarction.

    Overview/Details:Aspirin received within 24 hours of arrival to the hospital for patients having an AcuteMyocardial Infarction (AMI).

    Rationale:The early use of aspirin in patients with Acute Myocardial Infarction results in asignificant reduction in adverse events and subsequent mortality.

    Measure-Related OutcomesMortality: Decreased mortalityReadmissions within 30 days: DecreasedReliability: Increased delivery of evidence based careImprovement noted as: Increase in rate

    Patient Settings/Services:Emergency Services/DepartmentIntensive Care Units

    Medical/Surgical units

    Indicator Name: Aspirin on arrival

    Numerator: AMI patients who received aspirin within 24 hours beforeor after hospital arrival

    Denominator: AMI patients who are age >= 18 years

  • 7/25/2019 JCI I-AMI-1 ASA on Arrival Specifications SAMPLE 2012

    8/14

    Version 2.0

    UseCtrl + Homekeys to go to the title page

    Specification Manual for the Joint Commission International Library of MeasuresVersion 2.0, effective for January 2013 discharges (1st Quarter 2013)2011 Joint Commission International

    Measure-RelatedDomains of

    Performance

    Measure-RelatedQuality Improvement and

    Patient Safety (QPS)Standards

    QPS.3 through QPS.3.3 IntentStatement Clinical Areas

    Measure-RelatedClinical

    CareProgram

    Certification

    Measure-Topic

    RelatedI-PatientSafetyGoals

    Appropriateness

    Availability

    Continuity

    Effectiveness

    Timeliness

    QPS.3.1

    1. patient assessments

    5. antibiotic and other

    medication use

    AMI Goal 1

  • 7/25/2019 JCI I-AMI-1 ASA on Arrival Specifications SAMPLE 2012

    9/14

    Version 2.0

    UseCtrl + Homekeys to go to the title page

    Specification Manual for the Joint Commission International Library of MeasuresVersion 2.0, effective for January 2013 discharges (1st Quarter 2013)2011 Joint Commission International

    I-AMI-1

    Measure Details

    Reasons and Implications: The benefits of aspirin therapy on mortality arecomparable to fibrinolytic therapy. The combination of aspirin and fibrinolytics providesadditive benefit for patients with ST-elevation myocardial infarction and aspirin is alsoeffective in patients with non-ST-elevation Myocardial Infarction. Clinical guidelinesstrongly recommend aspirin for patients hospitalized with AMI.

    Data Collection:Retrospective data sources for the required data elements include administrative dataand medical records.

    Numerator: AMI patients who received aspirin within 24 hours before or after hospitalarrival

    Data Elements:

    Aspirin Received Within 24 Hours Before or After Hospital Arrival

    Inclusions to the numerator population: Not Applicable

    Exclusions from the numerator population: None

    Denominator: AMI patients who are >= 18 years

    Data Elements:

    Arrival Date

    Birthdate

    Discharge Disposition

    ICD Principal Diagnosis Code

    Reason for No Aspirin on Arrival

    Inclusions to the denominator population: Patients with ICD Principal DiagnosisCodefor AMI as defined inAppendix A, Table 1.1.

    Exclusions from the denominator population: Patients less than 18 years of age

    Patients who left against medical advice

    Patients who expired on day of or day after arrival

  • 7/25/2019 JCI I-AMI-1 ASA on Arrival Specifications SAMPLE 2012

    10/14

    Version 2.0

    UseCtrl + Homekeys to go to the title page

    Specification Manual for the Joint Commission International Library of MeasuresVersion 2.0, effective for January 2013 discharges (1st Quarter 2013)2011 Joint Commission International

    Patients with a documented Reason for No Aspirin on Arrival

    Patients discharged/transferred to another hospital for inpatient care

  • 7/25/2019 JCI I-AMI-1 ASA on Arrival Specifications SAMPLE 2012

    11/14

    Version 2.0

    UseCtrl + Homekeys to go to the title page

    Specification Manual for the Joint Commission International Library of MeasuresVersion 2.0, effective for January 2013 discharges (1st Quarter 2013)2011 Joint Commission International

    I-AMI-1

    References

    Anderson JL, Adams CD, Antman EM, Bridges CR, Califf RM, Casey DE Jr, et al.ACC/AHA 2007 guidelines for the management of patients with unstableangina/nonST-elevation myocardial infarction: a report of the American Collegeof Cardiology/American Heart Association Task Force on Practice Guidelines(Writing Committee to Revise the 2002 Guidelines for the Management of PatientsWith Unstable Angina/NonST-Elevation Myocardial Infarction): developed incollaboration with the American College of Emergency Physicians, AmericanCollege of Physicians, Society for Academic Emergency Medicine, Society forCardiovascular Angiography and Interventions, and Society of Thoracic Surgeons.J Am Coll Cardiol.2007;50:e1157.

    Antman EM, Anbe DT, Armstrong PW, Bates ER, Green LA, Hand M, et al.ACC/AHA guidelines for the management of patients with ST-elevation myocardialinfarction: a report of the American College of Cardiology/American Heart

    Association Task Force on Practice Guidelines (Committee to Revise the 1999Guidelines for the Management of Patients With Acute Myocardial Infarction).2004.

    Krumholz HM, Anderson JL, Bachelder BL, Fesmire FM, Fihn SD, Foody JM, etal. ACC/AHA 2008 performance measures for adults with ST-elevation and nonST-elevation myocardial infarction: a report of the American College ofCardiology/American Heart Association Task Force on Performance Measures(Writing Committee to Develop Performance Measures for ST-Elevation and Non

    ST-Elevation Myocardial Infarction). J Am Coll Cardiol.2008;52:204699. Randomized trial of intravenous streptokinase, oral aspirin, both or neither among

    17,187 cases of suspected acute myocardial infarction: ISIS-2. ISIS-2 (SecondInternational Study of Infarct Survival) Collaborative Group. Lancet. 1988 Aug13;2(8607):349w-60.

    Risk of myocardial infarction and death during treatment with low dose aspirin andintravenous heparin in men with unstable coronary artery disease. The RISCGroup. Lancet. 1990;336(8719):827-830.

    Theroux P, Ouimet H, McCans J et al. Aspirin, heparin, or both to treat acuteunstable angina. N Engl J Med.1988;319(17):1105-1111.

  • 7/25/2019 JCI I-AMI-1 ASA on Arrival Specifications SAMPLE 2012

    12/14

    Version 2.0

    UseCtrl + Homekeys to go to the title page

    Specification Manual for the Joint Commission International Library of MeasuresVersion 2.0, effective for January 2013 discharges (1st Quarter 2013)2011 Joint Commission International

    ICD Principal

    Diagnosis Code

    for Acute Myocardial

    Infarction(AMI)

    Patient Age

    Aspirin

    Received Within 24

    Hours Before or After

    Hospital Arrival

    Reason for

    No Aspirin on

    Arrival

    YES

    NO

    NO

    Case NOT in the I-AMI

    Initial Population

    Case NOT in the I-AMI

    Initial Population

    Case Met Measure and is in

    the NumeratorPopulation (E)

    Case Did Not Meet the

    Measure and is in the Measure

    Population (D)

    NO

    < 18 years

    YES

    YES

    Run inpatient cases with ICD Principal

    Diagnosis Code or principal diagnosis

    of AMI, Appendix A, Table 1.1

    Patient Age (in years) =

    Admission DateBirthdate

    Run case for patients = > 18 years old

    Check if aspirin was received within 24

    hours before or after hospital arrival

    Check if theres a documented reason

    for no aspirin on arrival

    I-AMI-1 Aspirin on Arrival

    Discharge

    Disposition

    START

    2, 3, or 4a

    Check if patient expired on the day of

    or day after arrival or signed out of the

    hospital against medical advice (AMA)

    or was transferred to another hospital

    for inpatient care

    Arrival Date

    Case Did Not Meet the

    Measure and is in the

    Measure

    Population (D)

    UTDCheck what the earliest documented

    date the patient arrived at the hospital

    Case Not in Measure

    Population-Excluded (B)

    Case Not in Measure

    Population-Excluded (B)

    = > 18years

    Valid Date

    1, 4b, 5, or 6

    STOP

  • 7/25/2019 JCI I-AMI-1 ASA on Arrival Specifications SAMPLE 2012

    13/14

    Version 2.0

    UseCtrl + Homekeys to go to the title page

    Specification Manual for the Joint Commission International Library of MeasuresVersion 2.0, effective for January 2013 discharges (1st Quarter 2013)2011 Joint Commission International

    I-AMI-1 Aspirin at ArrivalWord Algorithm

    Numerator:Acute Myocardial Infarction (AMI) patients who received aspirin within 24 hoursbefore or after hospital arrival

    Denominator:AMI patients

    1. Start processing. Run cases that are included in the I-AMI Initial Patient Populationand pass the edits defined in the Data Processing Flow: Clinical data abstractionthrough this measure.

    2. Check Arr ival Date

    a. If Arrival Date equals Unable to Determine (UTD), the case will proceed to aMeasure Category Assignment of D and will be in the Measure Population.Stop processing.

    b. If Arrival Date equals a Non Unable to Determine value, continue processing andproceed to the check Discharge Disposition.

    3. Check Discharge Dispos it ion.a. If the Discharge Disposition equals 2, 3, or 4a, the case will proceed to a Measure

    Category Assignment of B and will not be in the measure population. Stopprocessing.

    b. If the Discharge Status is equals 1, 4b, 5, or 6, continue processing and proceed toAspirin Received Within 24 Hours Before or After Hospital Arrival.

    4. Check Asp ir in Received Within 24 HoursBefore or After Hosp ital Arr ivala. If Aspirin Received Within 24 Hours Before or After Hospital Arrival equals yes, the

    case will proceed to a Measure Category Assignment of E and will be in theNumerator Population. Stop processing.

    b. If Aspirin Received Within 24 Hours Before or After Hospital Arrival equals No,continue processing and proceed to check Reason for No Aspirin on Arrival.

    5. Check Reason for No A spir in on Arr iva la. If Reason for No Aspirin on Arrival equals Yes, the case will proceed to a Measure

    Category Assignment of B and willnot be in the Measure Population. Stop

    processing.b. If Reason for No Aspirin on Arrival equals No, the case will proceed to a MeasureCategory Assignmentof D and will be in the Measure Population. StopProcessing

  • 7/25/2019 JCI I-AMI-1 ASA on Arrival Specifications SAMPLE 2012

    14/14

    Version 2.0

    UseCtrl + Homekeys to go to the title page

    Specification Manual for the Joint Commission International Library of MeasuresVersion 2.0, effective for January 2013 discharges (1st Quarter 2013)2011 Joint Commission International

    Measure Calculation:

    After the case data abstraction and data flow is completed, circle the assignedMeasure Category Assignment (MCA)Letter for each measure as guided by theallowable answer value text:

    I-AMI-1 B-Excluded D-Not metmeasure*

    E-Met/Passedmeasure**

    When calculating measure rate for all abstracted cases in the discharge month:Numerator cases = EDenominator cases = D plus E

    Divide the numerator counts by the denominator counts and X 100 = percentage

    rate of measure compliance with recommended standard of care

    Glossary Terms:*Not Met Measurerefers to a medical record which does not contain all of the criteriarequired to be part of the measures numerator population. **Met Measurerefers to a medical record which contains all of the criteria required tobe part of the measures numerator population.